1. Home
  2. CMND vs ACON Comparison

CMND vs ACON Comparison

Compare CMND & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$2.66

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$3.79

Market Cap

4.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMND
ACON
Founded
2017
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
4.4M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CMND
ACON
Price
$2.66
$3.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$23.00
AVG Volume (30 Days)
134.2K
2.4M
Earning Date
01-20-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,483.00
Revenue This Year
N/A
$71.77
Revenue Next Year
N/A
$80.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.91
52 Week Low
$1.74
$3.68
52 Week High
$60.80
$692.84

Technical Indicators

Market Signals
Indicator
CMND
ACON
Relative Strength Index (RSI) 64.09 38.53
Support Level $2.12 $3.68
Resistance Level $2.78 $4.23
Average True Range (ATR) 0.29 0.54
MACD -0.03 -0.09
Stochastic Oscillator 94.48 1.76

Price Performance

Historical Comparison
CMND
ACON

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: